Cynosure (NSDQ:CYNO) said it won marketing approval for its PicoSure laser in South Korea and Taiwan.
Cynosure Inc.
Cynosure inks $10M settlement with Tria Beauty
Is premium pricing a thing of the past? | MassDevice.com On Call
MASSDEVICE ON CALL — In the pre-Obamacare world, medical device companies were able to price their products at a premium, justified by improvements in quality that were in some cases marginal. But premium pricing "typically becomes an easy target for disruption through product innovation in many other technology industries, especially when the market place is crowded with competitors," writes Mohit Kaushal, a partner at Aberdare Ventures in San Francisco.
Listen to Cynosure’s Q3 2013 earnings call
Cynosure shares fall on slide to Q3 red
Endo Health taps new CFO from Becton Dickinson | Personnel Moves
Cynosure falls back to earth after reporting Q2 results
Cynosure closes $287 Palomar Medical buyout
J&J struggles to bring Synthes into the fold | MassDevice.com On Call
MASSDEVICE ON CALL — Michael Orsinger, the J&J executive in charge of the recently formed DePuy Synthes unit, said "less than half of the necessary work" to incorporate Synthes is complete, according to an interview with Swiss business newspaper Finanz und Wirtschaft.
Cynosure’s Q1 earnings miss expectations
Cynosure snaps up Palomar Medical Technologies for $294 million
Aesthetic laser maker Cynosure (NSDQ:CYNO) snapped up another competitor, acquiring Palomar Medical (NSDQ:PMTI) for $294 million in cash and stock.